Vincenza Calvaruso
Università degli Studi di Palermo
H-index: 51
Europe-Italy
Top articles of Vincenza Calvaruso
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Cholestasis impacts on performance of non invasive tests for ruling out high-risk esophageal varices in patients with primary biliary cholangitis and compensated advanced … | Digestive and Liver Disease | V Calvaruso C Celsa L Cristoferi M Scaravaglio L Capodicasa | 2024/2/1 |
Non-Invasive Diagnostic Tests for Portal Hypertension in Patients with HBV-and HCV-Related Cirrhosis: A Comprehensive Review | Ciro Celsa Marzia Veneziano Francesca Maria Di Giorgio Simona Cannova Antonino Lombardo | 2024/4/24 | |
Biochemical response to obeticholic acid drives liver stiffness variation over time and the risk of liver-related events in patients with primary biliary cholangitis | Digestive and Liver Disease | A De Vincentis F Terracciani D D'Amato M Scaravaglio P Invernizzi | 2024/2/1 |
Eliminating HCV infection from prisons in sicily: the SINTESI project | Digestive and Liver Disease | L Di Marco F Cartabellotta F Santangelo F Scalici R Insinna | 2024/2/1 |
OC. 05.7: CHOLESTASIS IMPACTS ON PERFORMANCE OF NON INVASIVE TESTS FOR RULING OUT HIGH-RISK ESOPHAGEALVARICES IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND COMPENSATED … | Digestive and Liver Disease | V Calvaruso C Celsa L Cristoferi M Scaravaglio L Capodicasa | 2024/4/1 |
Depth effect on point shear wave velocity elastography: Evidence in a chronic hepatitis C patient cohort | Ultrasound | Leonardo Rizzo Luca L’Abbate Massimo Attanasio Arturo Montineri Salvatore Magliocco | 2024/2 |
Real-life experience of long-term albumin treatment for the management of ascites in patients with decompensated cirrhosis accross Italy | Digestive and Liver Disease | E Pompili G Iannone C De Venuto S Piano A Lombardo | 2024/2/1 |
T. 07.2: LONG-TERM THERAPY WITH INTRAVENOUS HUMAN ALBUMIN INCREASE SURVIVAL IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND REFRACTORY ASCITES | Digestive and Liver Disease | A Lombardo L Capodicasa D Alaimo F Mercurio A Zimbardo | 2024/4/1 |
Efficacy and safety of lusutrombopag in a real-world Italian series of cirrhotic patients with severe thrombocytopenia undergoing invasive procedures: the Reality study | Digestive and Liver Disease | P Gallo A De Vincentis V Pace-Palitti M Russello A Vignone | 2024/2/1 |
Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort | United European Gastroenterology Journal | Loreta A Kondili Alberto Zanetto Maria Giovanna Quaranta Luigina Ferrigno Valentina Panetta | 2023/11/30 |
Long-term therapy with intravenous human albumin increase survival in patients with decompensated cirrhosis and refractory ascites | Digestive and Liver Disease | A Lombardo L Capodicasa D Alaimo F Mercurio A Zimbardo | 2024/2/1 |
Quantitative Evaluation by Digital Pathology of Immunohistochemical Expression of CK7, CK19, and EpCAM in Advanced Stages of NASH | Biomedicines | Daniela Cabibi Antonino Giulio Giannone Alberto Quattrocchi Vincenza Calvaruso Rossana Porcasi | 2024/2/16 |
Longer transplant-free and liver-related event-free survival in obeticholic acid-treated patients with primary biliary cholangitis compared to external controls from two large … | Digestive and Liver Disease | F Terracciani A De Vincentis D D'Amato P Invernizzi A Morgando | 2024/2/1 |
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV) | Viruses | Maria Giovanna Quaranta Luisa Cavalletto Francesco Paolo Russo Vincenza Calvaruso Luigina Ferrigno | 2024/4/26 |
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease | JHEP reports | Grazia Pennisi Marco Enea Mauro Viganò Filippo Schepis Victor de Ledinghen | 2023/9/1 |
Serum procalcitonin predicts mortality independently of the presence of ACLF in patients with cirrhosis and ascites hospitalized for suspicious infection and treated with … | Digestive and Liver Disease | M Bianchini C Celsa B Magro G Cavani P Giuffrida | 2023/3/1 |
T. 11.6 TREATMENT WITH GLECAPREVIR AND PIBRENTASVIR IS SAFE AND EFFECTIVE IN ITALIAN | Digestive and Liver Disease | E Mastrorocco A De Marco N Pugliese V Calvaruso M Masarone | 2023/3/1 |
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study | Liver International | Nicola Pugliese Vincenza Calvaruso Mario Masarone Roberta D'Ambrosio Sara Battistella | 2023/7 |
Heart rate variability is associated with disease severity and portal hypertension in cirrhosis | Progress in Neuro-Psychopharmacology and Biological Psychiatry | Beatrice R Benjamin Mathias Valstad Torbjørn Elvsåshagen Erik G Jönsson Torgeir Moberget | 2021/12/20 |
The burden of HDV infection: A ten-years’ experience of a sicilian tertiary centre of liver disease | Digestive and Liver Disease | GEM Rizzo D Ferraro G Rancatore P Graceffa G Falco | 2023/3/1 |
